Indian Peptide Suppliers

Rapidly growing hub for cost-effective peptide API manufacturing and pharmaceutical-grade synthesis. Major suppliers supporting global clinical trials and generic markets. Indian peptide manufacturing is centered in Mumbai and across Gujarat, with CDMOs and API manufacturers scaling capacity to serve both domestic and export markets. The Indian peptide market is projected to grow at a 15.8% CAGR through 2036, supported by expanding CDMO capacity from Piramal Pharma Solutions, Auro Peptides, and Neuland Laboratories (which commissioned a $30M commercial-scale peptide facility). Indian manufacturers typically offer competitive pricing for generic peptide APIs and intermediates, with documented regulatory submissions including US Drug Master Files (DMFs) and European Certificate of Suitability (CEP) filings. Quality verification and GMP compliance should be independently confirmed.

Directory listing last reviewed August 2026.